Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
REVAKINAGENE TARORETCEL-LWEY 200 000-440 000 CELL INTRAVITREAL IMPLANT (CDM RX-194403) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 24, 2026 , from http://ppman.hank.ai/transparency/procedure/RX-194403/by-state?code_type=CDM
“REVAKINAGENE TARORETCEL-LWEY 200 000-440 000 CELL INTRAVITREAL IMPLANT (CDM RX-194403) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/RX-194403/by-state?code_type=CDM. Accessed
October 24, 2026 .
“REVAKINAGENE TARORETCEL-LWEY 200 000-440 000 CELL INTRAVITREAL IMPLANT (CDM RX-194403) by State,” HANK Price Transparency ,
accessed October 24, 2026 ,
http://ppman.hank.ai/transparency/procedure/RX-194403/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
RX-194403 — Revakinagene Taroretcel-lwey 200 000-440 000 Cell Intravitreal Implant
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$656,250
National median
$612,500 – $875,000
IQR (p25 – p75)
2
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for RX-194403 (CDM), with interquartile range
State Median p25 p75
AL $656,250 $612,500 $875,000